Concepedia

Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients with Symptomatic Heart Failure and Systolic Dysfunction: The ECLIPSE International, Multicenter, Randomized, Placebo-controlled Trial

James E. Udelson, Cesare Orlandi, John Ouyang, Holly B. Krasa, Christopher A. Zimmer, Geir Frivold, W. Herbert Haught, Sheba Meymandi, Patricia Wedge, Marvin M. Konstam,

Journal of Cardiac Failure · 2007 · 10 citations · 0 references